Fresenius Medical Care (FMS) Financial Analysis & Valuation | Quarter Chart
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and pa... more
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services i... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $12.23B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Care Facilities |
| Country | DE | CEO | Helen Giza |
| IPO Date | 1996-09-17 | CAGR | 6.99% |
| Employees | 108,165 | Website | www.freseniusmedicalcare.com |
| Div. Yield | 70.46% | Payout Ratio | 45% |
| Buy Back Yield | 140.8% | Total Yield | 211.26% |
FMS chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $10.03B | P/E | 8.36 | Forward P/E | 8.39 | PEG | 2.02 |
| P/S | 0.04 | P/B | 0.05 | P/CF | 0.21 | P/FCF | 0.33 |
| Sales | $22.54B | Sales 1Y | -0.05% | Sales 3Y | -0.58% | Sales 5Y | 12.48% |
| EPS | $2.66 | EPS 1Y | 85.56% | EPS 3Y | 187.93% | EPS 5Y | 47.79% |
| Sales QoQ | 7.14% | EPS QoQ | 86.36% | Sales QoQ Avg | 0.96% | EPS QoQ Avg | 16.69% |
| Gross Margin | 26.36% | Operating Margin | 10.69% | Profit Margin | 4.83% | ROCE | 8.4% |
| ROA | 3% | ROE | 7% | Altman Z Score | 1.79 | Piotroski Score | 7 |
| Current Ratio | 1.2 | Quick Ratio | 0.86 | Cash Ratio | 0.18 | Op. CF Ratio | 0.03 |
| Debt/Equity | 0.83 | Debt/Assets | 0.35 | Lt Debt/Equity | 0.65 | Lt Debt/Cap. | 0.3 |
| Intrst Cov. | 5.64 | Inventory Turnover | 6.21 | Asset Turnover | 0.62 | Receivables Turnover | 5.23 |
| Enterprise Value | $10.03B | P/E Ratio | 8.36 |
| Forward P/E | 8.39 | PEG Ratio | 2.02 |
| P/S Ratio | 0.04 | P/B Ratio | 0.05 |
| P/CF Ratio | 0.21 | P/FCF Ratio | 0.33 |
| EPS | $2.66 | EPS Growth 1Y | 85.56% |
| EPS Growth 3Y | 187.93% | EPS Growth 5Y | 47.79% |
| Revenue Growth 1Y | -0.05% | Gross Margin | 26.36% |
| Operating Margin | 10.69% | Profit Margin | 4.83% |
| ROE | 7% | ROA | 3% |
| ROCE | 8.4% | Current Ratio | 1.2 |
| Quick Ratio | 0.86 | Cash Ratio | 0.18 |
| Debt/Equity | 0.83 | Interest Coverage | 5.64 |
| Altman Z Score | 1.79 | Piotroski Score | 7 |
Fresenius Medical Care (FMS) valuation & financials
Fresenius Medical Care (FMS) has a market capitalization of $12.23B and trades at a price-to-earnings ratio of 8.4. It operates in the Healthcare sector (Medical - Care Facilities).
Fresenius Medical Care's revenue grew -0.1% over the last year.
Fresenius Medical Care's next earnings report is scheduled for November 3, 2026 before market open (provider scheduled date); analysts estimate EPS of $0.60. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)